NET Patient Foundation Research Abstracts
NPF and NCRAS Public Health England partnership project has been compiling statistics on the incidence, prevalence and survival of NET patients in England using English cancer registry data, with an aim to also access Scottish, Welsh and Northern Irish cancer registry data to also get UK wide statistics.
We carried out four pieces of research in 2017, abstracts for which can be found below:
- The Incidence and Prevalence of Neuroendocrine Tumours in England.
- The 1- year survival rates for Neuroendocrine tumour patients in England.
- Metachronus primary cancers in Neuroendocrine tumour patients.
- Neuroendocrine Tumour patients experiences of support in the community setting across the treatment trajectory.
Presenting symptoms and delay in diagnosis of gastrointestinal and pancreatic Neuroendocrine tumours
Ileocolonic neuroendocrine tumours identified in the English bowel cancer screening programme
Self-reported side effects in neuroendocrine tumour (NET) patients prescribed somatostatin analogues – the role for specialist dietitians and nurses
- Assess what symptoms/side effects patients report on SSA’s.
- Assess the severity of symptoms/side effects reported by patients whilst on SSA’s.
- Produce recommendations on how to deal with symptoms commonly experienced by patients on SSA’s.
This study has been accepted to be published in the British Journal of Nursing.
Recent News
Follow on Care and Self Management Survey – Have your Say!
THIS SURVEY SHOULD TAKE APPROXIMATELY 8-10 MINUTES TO COMPLETE NCUK is a patient organisation and advocacy group bringing the views and experience of those affected by Neuroendocrine Cancer to the wider cancer, healthcare, policy-making and research communities to...
Nigel’s 100km London to Brighton Bike ride!
After a pasta – packed supper on Friday we tried on our new orange high vis cycling jerseys which Olivia had bought as a team strip and equally bright socks, ready for the start on Saturday morning. No one would fail to see us coming even in the dark shady lanes....
Neuroendocrine Cancer: Vitamins and Minerals – is supplementation necessary?
The presence and/or treatment of Neuroendocrine Cancer can disrupt normal digestive function - this can impact on our ability to absorb nutrients, including vitamins and minerals, from the food we eat. Malnutrition has been reported in up to 40% of patients...